{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05099679",
            "orgStudyIdInfo": {
                "id": "IRB-60375"
            },
            "secondaryIdInfos": [
                {
                    "id": "PROS0109",
                    "type": "OTHER",
                    "domain": "Stanford"
                },
                {
                    "id": "NCI-2022-02832",
                    "type": "OTHER",
                    "domain": "Clinical Trials Reporting Program"
                }
            ],
            "organization": {
                "fullName": "Stanford University",
                "class": "OTHER"
            },
            "briefTitle": "Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart Study",
            "officialTitle": "A Pilot Study for Optimizing Mental Wellbeing and Heart Health for Black Patients With Prostate Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "pilot-study-for-black-men-with-prostate-cancer-optimization-of-mental-and-heart-health-the-boom-heart-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-11-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-10-11",
            "studyFirstSubmitQcDate": "2021-10-27",
            "studyFirstPostDateStruct": {
                "date": "2021-10-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-08",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Stanford University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Pilot study to determine the feasibility of providing psychosocial and cardiac rehabilitation services to address socioeconomic health disparities and improve wellbeing for black men with prostate cancer.",
            "detailedDescription": "Subjects will see an oncology Associate Clinical Social Worker at Stanford's Cancer Center for a two hour psychosocial assessment. Subsequently participants will complete the psychosocial intake support session and elective additional counseling sessions (Part A) at the end of up to 8 counseling sessions (maximum sessions possible) or 20 weeks (+/- 4 weeks), whichever comes first. For participants who continue onto cardiac services (Part B), the participant will complete the cardiac rehabilitation exercise program within 12 weeks (+/- 2 weeks) of the first day of exercise start. The end of study will occur after the last cardiac rehabilitation exercise session (+ 2 weeks)."
        },
        "conditionsModule": {
            "conditions": [
                "Prostate Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Psychosocial intervention + Cardiac Rehab Services",
                    "type": "OTHER",
                    "description": "Cognitive Behavioral Therapy + Cardiac Rehab",
                    "interventionNames": [
                        "Behavioral: Cognitive behavioral therapy (supportive counseling)",
                        "Behavioral: Virtual Cardiac Rehabilitation"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Cognitive behavioral therapy (supportive counseling)",
                    "description": "Patients will complete a psychosocial intake that generally takes up to 2 hours, but the time required for the intake varies per patient. Subsequently they will be offered up to 7 optional counseling sessions with a clinical social worker",
                    "armGroupLabels": [
                        "Psychosocial intervention + Cardiac Rehab Services"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Virtual Cardiac Rehabilitation",
                    "description": "If eligible, patients will be referred to Movn Health Virtual Cardiac Rehabilitation to provide approximately 3 exercise sessions per week, with approximately eight coaching sessions over a 12 week period",
                    "armGroupLabels": [
                        "Psychosocial intervention + Cardiac Rehab Services"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportion of Completers",
                    "description": "Proportion of screened eligible participants who complete the initial 2-hour psychosocial support session intake.\n\nThe pilot study is considered feasible if the primary endpoint is met in at least 50% of patients. We will evaluate the 95% CI of the feasibility rate.",
                    "timeFrame": "12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Difference in Patient Health Questionnaire-9 (PHQ-9)",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Difference of General Anxiety Disorder-7 (GAD-7) score",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Difference of Functional Assessment of Cancer Therapy-Prostate (FACT-P) score",
                    "timeFrame": "12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria for Part A (Mental Health Services)\n\n* Self-Identify as Black and/or African American.\n* Diagnosed with prostate cancer currently or any time in the past (per medical history; pathology not required, active prostate cancer at time of enrollment is not required).\n* Males \\>= age 18.\n* All participants must have a life expectancy of \\> 6 months.\n* Participants must have the ability to understand and the willingness to sign a written informed consent document in English, and the willingness/ability to comply with the protocol activities.\n* Ability to wear a face mask during all in-person sessions (when required).\n\nParticipants must complete the psychosocial intake (Part A, Visit A1) in order to enroll in a cardiac rehabilitation program (Part B).\n\nAdditional Inclusion Criteria for Part B (Cardiac Services)\n\n* Have completed the psychosocial intake portion of Visit A1 (as documented by clinical social worker).\n* Meets at least one of the following (\\[a\\] or \\[b\\]):\n\n  1. planning to receive androgen deprivation on Day 1, or is currently, or was formerly, on androgen deprivation therapy. It is acceptable for participant to switch/transition to another form of androgen deprivation therapy while in the study. Participant may be receiving or planning to receive additional systemic therapy concurrent with androgen deprivation.\n\n     \\^ treatment with single agent testosterone-blocking agents (such as, but not limited to bicalutamide) will also be eligible\n\n     OR\n  2. patients with a cardiac risk factor may enroll. Cardiac risk factors include, but are not restricted to: pre-hypertension, hypertension, metabolic syndrome, tobacco history, coronary artery disease, CVA/TIA, peripheral vascular disease, obesity, hypercholesterolemia, hyperglycemia, heart failure, or any other cardiac condition based on the discretion of the investigators.\n* Participants must have an ECOG Performance Status of \\<= 2 or at the investigator's discretion, will have the ability to participate in a cardiac rehab program.\n* Participants must be able and willing to follow the cardiac rehabilitation activities.\n* Participant must have a smartphone or tablet to use for the cardiac rehabilitation app.\n\nExclusion Criterion for Part A (Mental Health Services)\n\n\\* Actively engaging in self harm, or currently on a 5150 or 5250.\n\nExclusion Criteria for Part B (Cardiac Services)\n\n* Uncontrolled angina, active acute coronary syndrome (e.g., unstable angina or acute MI) or poorly controlled arrhythmias.\n* In the opinion of the Principal Investigator, have a clinically significant comorbid disease that is likely to affect the ability of the patient to complete the trial, interfere with their ability with measurement of self-reported outcomes.",
            "healthyVolunteers": false,
            "sex": "MALE",
            "genderBased": true,
            "genderDescription": "Self-Identify as Black and/or African American",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sneha Mohile",
                    "role": "CONTACT",
                    "phone": "(650) 725-5459",
                    "email": "smohile@stanford.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Alice Fan, MD",
                    "affiliation": "Stanford University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford University",
                    "status": "RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sneha Mohile",
                            "role": "CONTACT",
                            "email": "smohile@stanford.edu"
                        },
                        {
                            "name": "Alice C Fan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011471",
                    "term": "Prostatic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005834",
                    "term": "Genital Neoplasms, Male"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000005832",
                    "term": "Genital Diseases, Male"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000011469",
                    "term": "Prostatic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14335",
                    "name": "Prostatic Neoplasms",
                    "asFound": "Prostate Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8946",
                    "name": "Genital Neoplasms, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8944",
                    "name": "Genital Diseases, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14333",
                    "name": "Prostatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}